252 related articles for article (PubMed ID: 2629366)
1. [The anti-arrhythmia effect and hemodynamic effects of Bonnecor in intravenous administration].
Volkmann H; Kühnert H; Dannberg G; Küch N; Büttner A
Z Gesamte Inn Med; 1989 Dec; 44(23):707-11. PubMed ID: 2629366
[TBL] [Abstract][Full Text] [Related]
2. [Hemodynamic and clinical studies with Bonnecor--a new anti-arrhythmia drug].
Assmann I; Kassel P; von Knorre G
Z Gesamte Inn Med; 1990 Dec; 45(23):703-8. PubMed ID: 1714669
[TBL] [Abstract][Full Text] [Related]
3. [Cibenzoline: electrophysiologic effects of a new class I anti-arrhythmia agents in supraventricular tachycardia].
Pfitzner P; Manz M; Schütz R; Lüderitz B
Z Kardiol; 1989 Oct; 78(10):654-60. PubMed ID: 2686252
[TBL] [Abstract][Full Text] [Related]
4. [Electrophysiologic effects of diprafenone in supraventricular and ventricular tachycardia].
Manz M; Beermann J; Gerckens U; Lüderitz B
Z Kardiol; 1986 Dec; 75(12):757-63. PubMed ID: 3825226
[TBL] [Abstract][Full Text] [Related]
5. [Terminating supraventricular tachycardia with adenosine--comparing the effectiveness of 12 mg and 18 mg].
Weismüller P; Kattenbeck K; Heinroth KM; Ranke C; Trappe HJ
Dtsch Med Wochenschr; 2000 Aug; 125(33):961-9. PubMed ID: 10994404
[TBL] [Abstract][Full Text] [Related]
6. [Comparative evaluation of the effects of ethacizine and Bonnecor in the treatment of supraventricular paroxysmal tachycardia].
Lukoshiavichiute AI; Gedrimene DA; Fol'kman G
Kardiologiia; 1991 Jan; 31(1):67-70. PubMed ID: 2046254
[TBL] [Abstract][Full Text] [Related]
7. [Effect of body position on the ability to initiate paroxysmal supraventricular reentry tachycardias and on the conduction system properties of the reentry circuit].
Dannberg G; Volkmann H; Kühnert H
Z Gesamte Inn Med; 1987 Jun; 42(11):289-94. PubMed ID: 3660882
[TBL] [Abstract][Full Text] [Related]
8. Electrophysiologic effects and therapeutic efficacy of intravenous flecainide for termination of paroxysmal supraventricular tachycardia.
Gambhir DS; Bhargava M; Arora R; Khalilullah M
Indian Heart J; 1995; 47(3):237-43. PubMed ID: 7558090
[TBL] [Abstract][Full Text] [Related]
9. [Acute therapy of tachycardic arrhythmias. 2: Supraventricular tachycardia--atrioventricular tachycardia (WPW syndrome)].
Gonska BD; Rab J
Fortschr Med; 1995 Mar; 113(7):87-9. PubMed ID: 7750890
[No Abstract] [Full Text] [Related]
10. [Therapeutic electrical procedures in recurring, drug refractory tachycardias. I. Antitachycardiac implantable pacemaker systems].
Volkmann H; Paliege R; Kühnert H; Lungershausen W; Rupprecht J
Z Gesamte Inn Med; 1986 Dec; 41(24):676-82. PubMed ID: 3564591
[TBL] [Abstract][Full Text] [Related]
11. [The usefulness of adenosine triphosphate in supraventricular paroxysmal tachycardias].
Jornet A; Palet J; Usón M; Petit M
Rev Clin Esp; 1993 Feb; 192(2):70-2. PubMed ID: 8460236
[TBL] [Abstract][Full Text] [Related]
12. Intravenous calcium chloride in the conversion of paroxysmal supraventricular tachycardia to normal sinus rhythm.
O'Brien JF; Tremml GP; Falk JL
Am J Emerg Med; 1996 Jan; 14(1):50-2. PubMed ID: 8630157
[TBL] [Abstract][Full Text] [Related]
13. [The anti-arrhythmia activity and effect on the heart conduction system of the new anti-arrhythmia preparation bonnecor].
Sokolov SF; Golitsyn SP; Malakhov VI; Bankuzov VA; Koltunova MI; Golitsyn LS
Farmakol Toksikol; 1990; 53(3):57-60. PubMed ID: 2387385
[TBL] [Abstract][Full Text] [Related]
14. [Electrophysiologic effect of sotalol in supraventricular tachycardias].
Borggrefe M; Breithardt G
Z Kardiol; 1985 Sep; 74(9):506-11. PubMed ID: 4060828
[TBL] [Abstract][Full Text] [Related]
15. [Exogenous adenosine as an anti-arrhythmia agent].
Tebbenjohanns J; Pfeiffer D; Schumacher B; Korte T; Jung W; Lüderitz B
Z Kardiol; 1996; 85 Suppl 6():191-9. PubMed ID: 9064965
[TBL] [Abstract][Full Text] [Related]
16. [Clinical experience with propafenone in paroxysmal supraventricular reciprocating tachycardias].
Furlanello F; Vergara G; Dal Forno P; Disertori M; Inama G
G Ital Cardiol; 1984 May; 14(5):379-80. PubMed ID: 6468821
[TBL] [Abstract][Full Text] [Related]
17. [Administration of adenosine for termination of atrioventricular nodal reentry tachycardia: induction of atrial fibrillation with rapid conduction over an accessory pathway and unmasking of concomitant Wolff-Parkinson-White syndrome].
Drescher S; Bosch RF; Mewis C; Kühlkamp V
Z Kardiol; 2000 Jun; 89(6):522-6. PubMed ID: 10929437
[TBL] [Abstract][Full Text] [Related]
18. [Antitachycardia pacing therapy in supraventricular tachycardia using the microcomputer-guided Tachylog 651 pacemaker].
Gerckens U; Manz M; Kirchhoff PG; Lüderitz B
Z Kardiol; 1986 Aug; 75(8):473-9. PubMed ID: 3776286
[TBL] [Abstract][Full Text] [Related]
19. [Amiodarone-induced hyperthyroidism causing progression of arrhythmia].
Pintér A; Zámolyi K; Székely A; Préda I
Orv Hetil; 1994 Jul; 135(28):1535-8. PubMed ID: 8058296
[TBL] [Abstract][Full Text] [Related]
20. [Efficacy and safety of adenosine triphosphate in the control of supraventricular paroxysmal tachycardia].
Brandão L; de Sousa J; Barreiros MC; Vagueiro MC; Amram SS
Rev Port Cardiol; 1994 Mar; 13(3):197-202, 191. PubMed ID: 8049086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
